Bicillin C-R Suspension For Injection 300000-300000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Bicillin C-R: Suspension for injection (300000-300000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PENICILLIN G BENZATHINE; PENICILLIN G PROCAINE (pen i SILL in G BEN za thine; pen i SILL in G proh KEYN) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Bicillin C-R 1,200,000units/2mL Suspension for Injection

NDC: 607930600
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pneumonia, Upper Respiratory Tract Infections, Erysipelas, Skin And Skin Structure Infections, Otitis Media, Scarlet Fever

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from freezing
Bicillin C-R 1,200,000units/2mL Suspension for Injection

Reported Side Effects for Bicillin C-R 1,200,000units/2mL Suspension for Injection

Inflamed Blood Vessels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Chills Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Eosinophilia Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Itching Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Fever Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Exfoliative Dermatitis Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Tongue Discoloration Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Bowel Necrosis Incidence:
2.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Bicillin C-R

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5